110813 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
CRYPTIC PROTEINS EXPRESSED FROM DEFECTIVE VIRAL GENOMES INTERFERE WITH INFLUENZA VIRUS REPLICATION
#2VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS
#3RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#4ASSAY AND MEDICAMENT
#5Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer
#6Assay and medicament
#7System and Method for Managing Animal Cancers by Disabling the Cancer Cells Ability to Reproduce
#8RNA virus vectors carrying DAI and RIPK3
#9Method for the separation of virus compositions including depletion and purification thereof
#10Influenza virus vector for virotherapy
#11ASSAY AND MEDICAMENT
#12Influenza virus vector for virotherapy
#13Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#14Replication deficient influenza virus for the expression of heterologous sequences
#15Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#16Anti-viral protection with viruses containing defective genome segments
#17NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#18ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#19REPLICATION DEFICIENT INFLUENZA VIRUS FOR THE EXPRESSION OF HETEROLOGOUS SEQUENCES
#20Methods for the propagation of modified influenza viruses in embryonated eggs
#21Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#22Methods and interferon deficient substrates for the propagation of viruses